optic neuropathy semaglutide may increase risk for nonarteritic anterior ischemic The obesity drug semaglutide (Wegovy)
Description
Get FDA-cited rates and how long each lasts.
The future is so promising
Elevated dopamine transporter density may be a consequence of chronic treatment rather than a marker for the disorder and may have implications for the effectiveness of long-term treatment.
Expected FDA decision: 2026 My take: We need to stay ahead of the curve
Spironolactone is a medication used in several medical settings
It mimics a natural hormone that regulates appetite and blood sugar
